Medicina Legal, Psiquiatría y Patología
Departamento
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (112)
2024
2023
-
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response
OncoImmunology, Vol. 12, Núm. 1
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Correlation Between Endoglin and Malignant Phenotype in Human Melanoma Cells: Analysis of hsa-mir-214 and hsa-mir-370 in Cells and Their Extracellular Vesicles
Advances in experimental medicine and biology, Vol. 1408, pp. 253-272
-
Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 18, pp. 3744-3758
-
Improved Sensitivity in BRAFV600E Detection in Combined Tissue and Extracellular Vesicle-Based Liquid Biopsy in Melanoma
Journal of Investigative Dermatology, Vol. 143, Núm. 8, pp. 1606-1610
-
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms
Molecular Oncology, Vol. 17, Núm. 4, pp. 582-597
2022
-
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
EMBO molecular medicine, Vol. 14, Núm. 3, pp. e14552
-
Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy
Journal of Clinical Medicine, Vol. 11, Núm. 6
-
Leukocyte telomere length in patients with schizophrenia and related disorders: a meta-analysis of case-control studies
Molecular Psychiatry, Vol. 27, Núm. 7, pp. 2968-2975
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
Nature medicine, Vol. 28, Núm. 4, pp. 752-765
-
Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies
Therapeutic Advances in Medical Oncology, Vol. 14
2021
-
An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad antitumor activity in humanized murine cancer models without toxicity
Clinical Cancer Research, Vol. 27, Núm. 11, pp. 3167-3177
-
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
Breast Cancer Research, Vol. 23, Núm. 1
-
Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics
EMBO Molecular Medicine, Vol. 13, Núm. 12
-
Tumor mutational burden assessment in non-small-cell lung cancer samples: Results from the TMB 2 harmonization project comparing three NGS panels
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5
2020
-
Combined MEK and PI3K/p110β inhibition as a novel targeted therapy for malignant mesothelioma displaying sarcomatoid features
Cancer Research, Vol. 80, Núm. 4, pp. 843-856
-
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
EBioMedicine, Vol. 53
-
Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state
Nature Medicine, Vol. 26, Núm. 12, pp. 1865-1877